Alto Neuroscience Starts Phase 2 Trial of ALTO-203 in Major Depressive Disorder Patients-May 2024-www.financetom.com

Alto Neuroscience Starts Phase 2 Trial of ALTO-203 in Major Depressive Disorder Patients

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Alto Neuroscience Starts Phase 2 Trial of ALTO-203 in Major Depressive Disorder Patients

Apr 3, 2024 8:40 AM

11:15 AM EDT, 04/03/2024 (MT Newswires) -- Alto Neuroscience ( ANRO ) said Wednesday it has started a phase 2 study of ALTO-203 in major depressive disorder patients.

Alto said it expects to enroll about 60 adult participants with MDD and anhedonia, with top-line data expected in H1 of 2025.

The company said ALTO-203 showed a favorable tolerability profile across three phase 1 trials and produced a variety of emotional and brain effects that support its antidepressant potential.

Price: 14.17, Change: +0.06, Percent Change: +0.43

Previous page： MGM Resorts International Q4 Earnings: Revenue Beat, EPS Beat, 'Strong Demand' To Start 2025, BetMGM On Track To Turn Profitable This Year Next page： Post Holdings Insider Sold Shares Worth $990,029, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

MGM Resorts International Q4 Earnings: Revenue Beat, EPS Beat, 'Strong Demand' To Start 2025, BetMGM On Track To Turn Profitable This Year

Feb 12, 2025

MGM Resorts International ( MGM ) shares are rising in extended trading Wednesday after the company reported better-than-expected financial results for the fourth quarter. Q4 Revenue: $4.35 billion, versus estimates of $4.27 billion Q4 Adjusted EPS: 45 cents, versus estimates of 30 cents Total revenue was down 1% on a year-over-year basis. Las Vegas Strip revenue came in at $2.2...

Post Holdings Insider Sold Shares Worth $990,029, According to a Recent SEC Filing

Feb 12, 2025

04:56 PM EST, 02/12/2025 (MT Newswires) -- David W Kemper, Director, on February 10, 2025, sold 8,939 shares in Post Holdings ( POST ) for $990,029. Following the Form 4 filing with the SEC, Kemper has control over a total of 29,722 common shares of the company, with 29,722 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1530950/000153095025000075/xslF345X05/wk-form4_1739397239.xml ...

Mexican breadmaker Bimbo issues bonds for $730 mln

Feb 12, 2025

MEXICO CITY, Feb 12 (Reuters) - Mexican breadmaker Grupo Bimbo on Wednesday announced a bond issuance on the local market for 15 billion pesos ($730 million), in two series maturing in three and seven years. Bimbo said it would use the proceeds from the debt offering, which was met with a demand of some 22 billion pesos, for regular operations...

Equinix forecasts quarterly, annual revenue below estimates as strong dollar weighs

Feb 12, 2025

Feb 12 (Reuters) - Equinix ( EQIX ) forecast first-quarter and annual revenue below estimates on Wednesday, hurt by a strong dollar amid rising concerns about hefty spending on data center expansion as businesses double down on generative AI adoption. Shares of the company fell more than 2% in extended trading. Massive spending on AI and infrastructure investments has come...